Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome
Clinical trial NCT04622761 · UNKNOWN
Trial details
- NCT number
- NCT04622761
- Sponsor
- The Clatterbridge Cancer Centre NHS Foundation Trust
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2025-11-02
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.